Characterization and localization of galanin receptors in human entorhinal cortex

被引:12
作者
Deecher, DC [1 ]
Mash, DC
Staley, JK
Mufson, EJ
机构
[1] Wyeth Ayerst Res, Womens Hlth Res Inst, Radnor, PA 19087 USA
[2] Univ Miami, Sch Med, Dept Neurol, Miami, FL 33101 USA
[3] Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
关键词
aging; autoradiography; cortical; Alzheimer's disease; neuropeptides; GppNHp;
D O I
10.1016/S0167-0115(97)01067-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The neuropeptide galanin (GAL) has a widespread distribution throughout the human cortex. The entorhinal cortex (ENT) plays a crucial role in the transfer of cortico-cortical information related to memory and displays severe degeneration in Alzheimer's disease (AD). However, very little is known about the pharmacology of the GAL receptor (GALR) in normal human ENT. Therefore, we pharmacologically visualized their distribution and characterized GALRs using in vitro receptor autoradiography and radioligand binding assays. Autoradiograms revealed intense GALR labeling, mainly in the substantia innominata, hypothalamus, the bed nucleus of the stria Its terminalis and within layers 2 and 4 of the ENT. Kinetic experiments showed that saturation of GALR sites by [I-125]GAL (human) (hGAL) occurred within 2 h and that this binding readily reversed in the presence of a GTP analog, but not in the presence of excess unlabeled hGAL. Analysis of [I-125]hGAL binding data from saturation experiments gave K-D values of 98.6+/-21.6 pM, B-max values of 52.9+/-32.4 fmol/mg protein and identified a high and low affinity state of the GALR. The presence of 5'-guanylylimidodiphosphate (GppNHp) or NaCl reduced the agonist labeling of hGALR in ENT membranes. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:149 / 159
页数:11
相关论文
共 54 条
[1]  
Asan E., 1990, DEMENTIA, V1, P18, DOI 10.1159/000107116
[2]   EVIDENCE THAT TRANSMITTER-CONTAINING DYSTROPHIC NEURITES PRECEDE THOSE CONTAINING PAIRED HELICAL FILAMENTS WITHIN SENILE PLAQUES IN THE ENTORHINAL CORTEX OF NONDEMENTED ELDERLY AND ALZHEIMERS-DISEASE PATIENTS [J].
BENZING, WC ;
BRADY, DR ;
MUFSON, EJ ;
ARMSTRONG, DM .
BRAIN RESEARCH, 1993, 619 (1-2) :55-68
[3]   HUMAN GALANIN - PRIMARY STRUCTURE AND IDENTIFICATION OF 2 MOLECULAR-FORMS [J].
BERSANI, M ;
JOHNSEN, AH ;
HOJRUP, P ;
DUNNING, BE ;
ANDREASEN, JJ ;
HOLST, JJ .
FEBS LETTERS, 1991, 283 (02) :189-194
[4]   Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections [J].
Braak, Heiko ;
Braak, Eva .
BRAIN PATHOLOGY, 1991, 1 (03) :213-216
[5]  
Bylund D.B., 1990, METHODS NEUROTRANSMI, P1
[8]   Galanin-acetylcholine interactions: Relevance to memory and Alzheimer's disease [J].
Crawley, JN .
LIFE SCIENCES, 1996, 58 (24) :2185-2199
[9]   FUNCTIONAL INTERACTIONS OF GALANIN AND ACETYLCHOLINE - RELEVANCE TO MEMORY AND ALZHEIMERS-DISEASE [J].
CRAWLEY, JN .
BEHAVIOURAL BRAIN RESEARCH, 1993, 57 (02) :133-141
[10]  
DEECHER DC, 1995, J PHARMACOL EXP THER, V275, P720